Laurel Wealth Advisors (North Carolina)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Laurel Wealth Advisors (North Carolina)'s GILD Position: Q1 2026 in Review
Laurel Wealth Advisors (North Carolina) sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 60 shares — an estimated $7.37K sold.
Laurel Wealth Advisors (North Carolina) first reported a position in GILD in Q1 2020 and held it in 19 quarters. The position peaked at $25K in Q2 2020. 2,320 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Laurel Wealth Advisors (North Carolina) reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
- Laurel Wealth Advisors (North Carolina) sold 60 Gilead Sciences shares in Q1 2026, an estimated $7.37K.
- Laurel Wealth Advisors (North Carolina) first reported a position in Gilead Sciences in Q1 2020 and held it in 19 quarters.
- Laurel Wealth Advisors (North Carolina)'s Gilead Sciences position peaked at $25K in Q2 2020.
- 2,320 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q1 2026, filed 13 May 2026.